Friday, October 23, 2026

AI Narrative Switched, Debt Yields Spike | The Weekly Wrap

CoreWeave’s rising debt yields and fading confidence in AI data-center economics frame a weekly review of Meta, Tesla, SpaceX, Netflix, French bonds and housing.

CRWV $30BTSLA $1.5T

Steve Eisman Oct 23 28 clicks

Oct 23 CRWV $30B

Our Views on CoreWeave

WHAT ARE WE DOING? “Contrarians At The Gate” 12 clicks

Oct 23 BE $56B

Bloom Energy (NYSE: BE) Q3 FY12/26 Earnings - Revenue Up 138% On The Datacenter Power Race

Cestrian Capital Research 8 clicks

From X

@DeepSailCapital Oct 7

Deep Sail Capital on X

$SHAZ - Breaking down here. Short opportunity. https://t.co/qK8bLsCrVP

@cfrischer1 Oct 7

Charles Frischer on X

$NN I understand we have strong support at key administrative levels but I believe they want to wait until after midterms. They don’t want any distractions before midterms. After midterms, full steam ahead.

@SouthernValue95 Oct 7

SouthernValue on X

Danaher $DHR is combining technology from several of its bioprocessing and life science companies with Lab Robotics startup Automata to launch an AI-powered robotic autonomous research lab. From the Press Release: Danaher's first AI-powered autonomous lab is designed to deliver: - Speed: Up to 8x faster discovery of affinity reagents, helping researchers get from idea to breakthrough sooner - Scale: Unlocking up to a tenfold increase in annual reagent generation, from tens to hundreds of reagents per year as the lab scales - Quality: Each design built in the lab would also be verified, tested and fed back to improve the next, without trading speed for scientific rigor - Sustainability: Over time, this approach is expected to complement traditional immunization-based methods used in the discovery of antibodies and other research tools Based at Abcam, a Danaher company, the lab uses AI to help create new affinity reagents, including antibodies, then builds and tests each one, feeding every result back into the model to improve the next design. The lab brings together industry-leading technologies and expertise from several Danaher operating companies, including Beckman Coulter Life Sciences, Cytiva, Genedata, Integrated DNA Technologies, and Molecular Devices, in one connected workflow. The device orchestration and robotic automation is the result of collaborative work with Automata*. This continuous design-make-test-learn loop can run in a fraction of the time it takes today, without trading speed for scientific rigor. This approach applies the same test-and-verify discipline of continuous improvement long used across Danaher operations to an AI-enabled laboratory environment. The lab is set to be an early proof point for how Danaher's smart instruments, AI-ready data, and expert agentic systems can accelerate scientific discovery and medical progress. https://t.co/mw00CBjDC4

@cfrischer1 Oct 7

Charles Frischer on X

$NN Given market trading, I assume NPRM won’t drop today. I think given the political nature of the opposition, Dec meeting post midterms looks most likely right now.

@SouthernValue95 Oct 7

SouthernValue on X

Also flagged by Wigg: $MSFT raising certain storage and VM prices +17-25% Feb 1 '27. https://t.co/6njOyE2drZ https://t.co/TEzhq9JJNo

@stockgutter Oct 7

SG on X

@DeepSailCapital did about 100% on $CAR sympathy this spring. From a lower base here $HTZ % returns could be much higher this time.

@ACapitalLP Oct 7 2 clicks

A Capital on X

Hmmmm $MIAX 👀 https://t.co/FWjrvjmJ0R https://t.co/uql6e5TGbP

@DeepSailCapital Oct 7

Deep Sail Capital on X

$HTZ is the first potential real short squeeze of any size we have tracked in the last 3 months. Not there yet, but it has all of the needed elements.

Philip Morris: Taking the Fight to the U.S.

Philip Morris reported Q3 growth across heated tobacco, combustibles and e-vapor in Europe while gaining U.S. nicotine-pouch share.

PM $314B

Librarian Capital's Research Library Oct 23 2 clicks

Amazon’s Trainium Takes a Strike at the Training King

Amazon’s Trainium3 adds native PyTorch training support, targeting CUDA-trained researchers with standard APIs, eager mode and…

AMZN $2.8T

SemiAnalysis Oct 23 7 clicks

Alphabet: Gemini 4 Argon Is Coming For ChatGPT's Lunch

Alphabet's Gemini 4 Argon aims to undercut rival AI models using proprietary TPUs, while Android, Siri and Google Cloud distribution…

GOOGL $3.9T

Dustin Quasney Oct 23 3 clicks

Capital Wars

CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a…

CRWV $30B

Net Interest Oct 23 11 clicks

Spotify 3Q’26: Built for the Background

Spotify's third-quarter results met or exceeded guidance, with 306 million Premium subscribers and €672 million operating income, while…

SPOT $108B

MBI Deep Dives Oct 23 3 clicks

Big Tech Will Spend More on AI This Year Than Walmart Sells

Alphabet, Amazon, Meta and Microsoft plan nearly $800 billion of AI infrastructure spending, testing whether incremental returns can stay…

GOOGL $3.9TMSFT $3.9T

Ezra's Notes Oct 23 5 clicks

TSOH Weekly Roundup (10/23/2026)

TSOH Weekly Roundup covers Ally’s improving credit and capital returns, Pepsi’s weak beverage brands, and Match Group’s plan to revive…

ALLY $12BMTCH $11B

TSOH Investment Research Oct 23 4 clicks

Texas Instruments (NASDAQ: TXN) Stock Rating: HOLD After Q3 FY12/26 Earnings

Texas Instruments reported Q3 revenue of $6.06 billion, up 28%, with 47% operating margin and Q4 guidance above seasonal norms; Cestrian…

TXN $260B

Cestrian Capital Research Oct 23 6 clicks

Tempus AI: Moderna's New Cancer Vaccine Partner Is The Pick Of The AI Biotech Bunch

TEM $11BMRNA $98B

Edmund Ingham Oct 23 4 clicks

Research & Analysis: ERock, Inc. (NYSE: EROC)

ERock’s modular microgrids bridge data-center power gaps years before grid interconnects, with Meta and Anthropic projects filling capacity…

EROC $453M

Monte Independent Investment Research Oct 23 9 clicks

Putting bear cases to rest

Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as…

MEDP $18B

Best Anchor Stocks Oct 23 14 clicks

Lockheed Martin Q3 FY12/26 Earnings Review

Lockheed Martin's Q3 missile sales rose 24% on PAC-3, THAAD, GMLRS and PrSM ramps, lifting Missiles and Fire Control backlog to $142.5…

LMT $140B

Cestrian Capital Research Oct 23 5 clicks

Industry Primers Podcast: Natural Resources Royalty & Streaming, Part One: The Story

Franco-Nevada, Wheaton and Texas Pacific Land built royalty and streaming businesses by buying fixed shares of mines and wells, tracing the…

FNV $47BWPM $57B

Latticework by MOI Global Oct 23 4 clicks

Oscar Health: Up Over 200% From The March Lows, Still Room To Run (Ticker: OSCR)

Oscar Health raised 2026 operating earnings guidance to $600 million-$800 million after ACA-marketplace expansion drove 60% membership and…

OSCR $10B

Emerging Moats Research Oct 23 4 clicks

PYPD · long

Polypid LTD

PolyPid, an $80 million Israeli biotech, fell nearly 30% despite solving a clinical problem.

PYPD $106M

Value Investors Club Jul 25

It’s time to sell the winners again as Western Digital, Bloom report outstanding results, shares drop

Western Digital and Bloom Energy fell after strong quarterly results, extending the selloff in AI-linked stocks.

WDC $132BBE $56B

The Technology Letter Oct 22 5 clicks

Sharp Tech on Video: Netflix Angst, the End of the Internet, and Meta’s VR Glasses

Sharp Tech launches on video, covering Netflix, the internet’s future and Meta’s VR glasses.

NFLX $511BMETA $1.8T

Stratechery by Ben Thompson – On the business, strategy, and impact of technology. Oct 22 1 click

OCP 2026: MicroVCSELs are gaining attention, but microLEDs still have a case

Credo’s microVCSEL pivot targets 10–20m data-center links where copper falls short, while microLEDs compete nearer compute on integration,…

CRDO $28B

Vik's Newsletter Oct 22 5 clicks

Field Trip: AI Has to Be Seen to Be Believed

Seattle AI users report major productivity gains and expect firms to shift from OpenAI and Anthropic toward owned hardware, supporting…

NVDA $5.1T

Aurelion Research Oct 22 15 clicks

Lam Research Q1 FY6/27 Earnings Review

Lam Research reported $8.22 billion in Q1 FY6/27 revenue, with systems up 62% and operating margin reaching a record 40% as memory spending…

LRCX $326B

Cestrian Capital Research Oct 22 4 clicks

Friday, October 23, 2026

Deep Sail Capital on X

Charles Frischer on X

SouthernValue on X

Charles Frischer on X

SouthernValue on X

SG on X

A Capital on X

Deep Sail Capital on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 62 of 253

X accounts we follow

Investor letters we follow

Sectors